ROSA DAVID A (CEO and President) reported 1 transaction at NEUROONE MEDICAL TECHNOLOGIES CORP
Review the transaction codes below to understand the nature of each event.
Filed: 4/2/2025ACC: 0001540354-25-000003
DirectorOfficer· CEO and President
Since Feb 2026
-2.46K
Net shares
Net seller
$2.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
2.46K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.46K
Price / share
$0.85
Trade value
$2.09K
% of position
0.2%
3/31/2025
1.06M→1.06M
Total
Net shares
−2.46K
Net value
-$2.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2025 | F · Tax Withholding | −2.46K | $0.85 | $2.09K | 0.2% | 1.06M | 1.06M |
| Total | −2.46K | -$2.09K | ||||||
Derivative Transactions0
No derivative transactions reported